Opportunity
Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR
Response due
October 21, 2026
- Agency
- National Institutes of Health Olao
- Estimated value
- Not stated
Attachment: Notice of Intent
Key dates
- Posted
- October 15, 2026
- Response due
- October 21, 2026
Who is this buyer
Organization
Buying history
- Records255 total
- Opportunities / awards10 / 19
- Value range$0 – $30,482,226
- ActiveJuly 15, 2026 – October 15, 2026
What they buy
- Clinical (243)
- Administrative (12)
Set-asides used
- No Set aside used (68)
- Small Business Set Aside - Total (13)
Who holds their work today
- EAGLE HEALTH, LLC1 win · $30,482,226 · last February 1, 2020
Also open from this buyer
- NOI - Acquisition of orthopedic procedure for NHLBDue October 22, 2026 · Clinical
- NOI - A Non-Invasive Prognostic Biomarker - CirculDue October 23, 2026 · Clinical
- Notice of Intent to Sole Source – Guidehouse Digital LLC – Pediatric Oncology SupportDue October 19, 2026 · Clinical
- Sources Sought - BIOMEDICAL ENGINEERING TECHNICAL SUPPORT SERVICESDue October 22, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- No Set aside used
- NAICS
- 541380
- PSC
- Q301